AMLX · Company research
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 28.04 | $3,279,196,079.67 | 3229870079.67 | 40.1999985714285714 | — | — | — | 13.7109052656511977 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.